Successful Treatment of Hepatitis C Virus Infection Using Direct-Acting Antiviral Agents (DAAs) in Adolescents with Kidney Transplantation: A Case Series.
Conclusion: Post-transplantation treatment of chronic HCV is preferred in KTRs. The sofosbuvir/daclatasvir regimen as an interferon-free therapy is a safe, effective option for HCV infection in pediatric KTRs, who can tolerate sofosbuvir/daclatasvir well and respond favorably without significant adverse events.
PMID: 32606888 [PubMed]
Source: International Journal of Nephrology and Renovascular Disease - Category: Urology & Nephrology Tags: Int J Nephrol Renovasc Dis Source Type: research
More News: Dialysis | Girls | Hemodialysis | Hepatitis | Hepatitis C | Indonesia Health | Kidney Transplant | Kidney Transplantation | Liver | Liver Transplant | Nephrotic Syndrome | Pediatrics | Study | Thrombocytopenia | Transplant Surgery | Transplants | Urology & Nephrology | Virology